GlassScriptPhysician profile
Paul M Neumann
NPI 1114908480
$2,787.90
in general payments reported to CMS, 2019-2025
23 companies · $149 in 2025
The $149 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $361 · 2020: $325 · 2021: $197 · 2022: $1,318 · 2023: $242 · 2024: $196 · 2025: $149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $497 · Education: $89.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $497.05 |
| Education | $89.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scynexis, INC. | $1,123.55 | 2022 | |
| Abbvie INC. | $440.08 | 2019-2023 | |
| Pfizer INC. | $169.72 | 2019-2023 | |
| Astellas Pharma US INC | $157.57 | 2024-2025 | Veozah, Vesicare |
| Medtronic, INC. | $126.65 | 2022-2024 | Truclear, Surgisleeve |
| Avion Pharmaceuticals | $109.58 | 2019-2020 | |
| Exeltis, USA INC. | $102.35 | 2019-2025 | Slynd |
| Coopersurgical, INC. | $86.92 | 2019-2024 | Endosee, Paragard T 380a |
| Bayer Healthcare Pharmaceuticals INC. | $78.85 | 2019-2023 | |
| Sumitomo Pharma America, INC. | $59.96 | 2024 | Myfembree, Gemtesa |
| Evofem Biosciences, INC. | $57.90 | 2021 | |
| Therapeuticsmd, INC. | $45.30 | 2020-2021 | |
| Covidien LP | $32.81 | 2019-2020 | |
| Urovant Sciences INC | $32.11 | 2022 | |
| Exact Sciences Corporation | $27.47 | 2024 | Cologuard Collection Kit |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $25.32 | 2023 | |
| Mylan Pharmaceuticals INC. | $20.80 | 2019 | |
| Hologic Sales and Service, LLC | $19.15 | 2023 | Affirm Prone Biopsy System |
| Millicent US INC | $16.19 | 2025 | Intrarosa, Femring |
| Davol INC. | $14.96 | 2023 | Arista Ah Flexitip |
| Organon LLC | $14.78 | 2022 | |
| Merck Sharp & Dohme LLC | $13.79 | 2019 | |
| Ethicon US, LLC | $12.09 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Neumann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.